Covid-19 update: US firm Gilead in talks with Indian drug companies to produce ...

Coronavirus update: The discussion is taking place about their ability, under voluntary licenses, to produce remdesivir for Europe, Asia and the developing world through at least 2022.

from Hindustan Times - topnews https://ift.tt/2YIOvD4